We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

45 hedge funds and large institutions have $11.7M invested in Anixa Biosciences in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

531% more call options, than puts

Call options by funds: $164K | Put options by funds: $26K

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

2% more funds holding

Funds holding: 44 → 45 (+1)

0.07% less ownership

Funds ownership: 11.85% → 11.77% (-0.07%)

26% less capital invested

Capital invested by funds: $15.8M → $11.7M (-$4.08M)

Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
10
Reduced
8
Closed
5
Calls
$164K
Puts
$26K
Net Calls
+$138K
Net Calls Change
+$105K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$146K
2
Citadel Advisors
Citadel Advisors
Florida
+$121K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$111K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$84.6K
5
JP Morgan Chase
JP Morgan Chase
New York
+$83.4K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$418K
2
Jane Street
Jane Street
New York
-$266K
3
VF
Virtu Financial
New York
-$79K
4
BRWA
B. Riley Wealth Advisors
Florida
-$65.4K
5
Simplex Trading
Simplex Trading
Illinois
-$65.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
SS
26
Simplicity Solutions
Minnesota
$49.5K – – –
CAM
27
Concorde Asset Management
Michigan
$49.5K +$59.6K +15,481 New
NFG
28
Nations Financial Group
Iowa
$48K +$13.5K +3,500 +30%
IAIM
29
International Assets Investment Management
Florida
$46.4K – – –
WIM
30
Westside Investment Management
California
$44.2K +$53.2K +13,800 New
Charles Schwab
31
Charles Schwab
California
$40.9K – – –
Commonwealth Equity Services
32
Commonwealth Equity Services
Massachusetts
$34K +$40.7K +10,571 New
ATC
33
Adirondack Trust Company
New York
$25.1K – – –
Group One Trading
34
Group One Trading
Illinois
$19.1K +$23K +5,970 New
TWM
35
Tradition Wealth Management
Minnesota
$16K – – –
TRCT
36
Tower Research Capital (TRC)
New York
$10.1K -$871 -226 -7%
AA
37
Ancora Advisors
Ohio
$4.87K – – –
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$4K +$1.06K +275 +27%
Wells Fargo
39
Wells Fargo
California
$2.31K +$35 +9 +1%
LFG
40
Larson Financial Group
Missouri
$1.68K – – –
Osaic Holdings
41
Osaic Holdings
Arizona
$1.28K – – –
US Bancorp
42
US Bancorp
Minnesota
$1.28K – – –
BC
43
Barrett & Company
Rhode Island
$256 – – –
S
44
SignatureFD
Georgia
$182 +$220 +57 New
TAM
45
Tucker Asset Management
Colorado
$32 – – –
Jane Street
46
Jane Street
New York
– -$266K -61,810 Closed
VF
47
Virtu Financial
New York
– -$79K -18,409 Closed
Simplex Trading
48
Simplex Trading
Illinois
– -$65.3K -16,962 Closed
BRWA
49
B. Riley Wealth Advisors
Florida
– -$65.4K -15,200 Closed
ASN
50
Advisory Services Network
Georgia
– -$2.9K -674 Closed
1
2

ANIX Hedge Fund Activity: Q2 2023 in Review

45 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q2 2023, worth a combined $11.7M — down 26% from $15.8M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ANIX positions and 5 closed out — a net gain of 1 holder — while 10 added to existing stakes and 8 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $146K. The largest seller was Susquehanna International Group, cutting an estimated $418K.

  • 45 institutional investors held Anixa Biosciences (ANIX) as of Q2 2023, up from 44 in Q1 2023.
  • Funds reported $11.7M of Anixa Biosciences stock for Q2 2023, down 26% quarter-over-quarter.
  • 6 funds opened new Anixa Biosciences positions in Q2 2023 and 5 closed out, a net change of +1 holder.
  • The largest Anixa Biosciences buyer in Q2 2023 was Renaissance Technologies, an estimated $146K added.
  • The largest Anixa Biosciences seller in Q2 2023 was Susquehanna International Group, an estimated $418K sold.

Based on aggregated 13F filings for Q2 2023.